1. Home
  2. CRNT vs ATYR Comparison

CRNT vs ATYR Comparison

Compare CRNT & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.07

Market Cap

213.6M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.43

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNT
ATYR
Founded
1996
2005
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
49.2M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
CRNT
ATYR
Price
$2.07
$0.43
Analyst Decision
Strong Buy
Hold
Analyst Count
2
9
Target Price
$3.50
$3.67
AVG Volume (30 Days)
320.3K
605.1K
Earning Date
05-19-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.98
EPS
N/A
N/A
Revenue
N/A
$190,000.00
Revenue This Year
$9.11
N/A
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$0.40
52 Week High
$3.29
$6.50

Technical Indicators

Market Signals
Indicator
CRNT
ATYR
Relative Strength Index (RSI) 40.07 34.21
Support Level $1.99 $0.40
Resistance Level $2.36 $0.59
Average True Range (ATR) 0.06 0.04
MACD 0.00 -0.01
Stochastic Oscillator 14.81 0.14

Price Performance

Historical Comparison
CRNT
ATYR

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: